Miajas, Rolando A.

HRN: 22-97-97  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/03/2023
05/10/2023
IV
600mg
Q8hrs
Exfoliative Dermatitis Superimposed With Bacterial Infection
Waiting Final Action 
05/03/2023
CO-AMOXICLAV 625MG (TAB)
05/03/2023
05/10/2023
PO
625mg
BID
Exfoliative Dermatitis Superimposed With Bacterial Infection
Waiting Final Action 
05/11/2023
CEFTRIAXONE 1G (VIAL)
05/11/2023
05/17/2023
IV
2g
OD
CAP-MR
Waiting Final Action 
05/11/2023
AZITHROMYCIN 500MG TABLET (TAB)
05/11/2023
05/15/2023
PO
500 Mg
OD
CAP-MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: